Frontlight ResearchEarly access
Alzheimer disease trials in Sweden
4 of 10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleThe Swedish BioFINDER 2 Study
- Where
- Malmö
- Age
- 20 years to 100 years
- People
- 2,950
- Run by
- Skane University Hospital
See details and how to joinNCT03174938 · EU 2024-511842-38-00 - Phase 1Taking peopleA positron emission tomography study of synaptic nerve cells proteins alpha-7 nicotinic acetylcholine receptors in brain of healthy volunteers and patients with mild cognitive impairment and Alzheimer´s disease.
- Where
- Huddinge, Solna
- Age
- 18 years and over
- People
- 45
- Run by
- Karolinska Institutet
See details and how to join2024-515935-31-04 - Phase 2Taking peopleOpen-label Extension Study in Participants With Early Alzheimer's Disease
- Where
- Gothenburg, Malmö, Stockholm
- Age
- 50 years to 85 years
- People
- 220 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07105709 - No phaseEnrolling by invitationMolecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
- Where
- Stockholm
- Age
- 30 years to 85 years
- People
- 100
- Run by
- Karolinska Institutet
See details and how to joinNCT06731842